Paralytic ileus due to a novel anticancer drug, nab-paclitaxel: A case report.
Nab-paclitaxel is a recently emerged chemotherapy drug, which is widely used for the treatment of multiple types of cancer. The prospects of this novel drug are very bright as a result of its higher efficacy and lower toxicity compared with paclitaxel. Hence, the side effect, even if rare, require attention in clinical practice. The present study described an unusual case of nab-paclitaxel-associated paralytic ileus. To the best of our knowledge, this is the first report to demonstrate that nab-paclitaxel may lead to acute intestinal obstruction. Since nab-paclitaxel will be used more frequently, this unusual side effect might be encountered by a clinical oncologist and must be treated correctly. This is the first reported case, to the best of our knowledge, of paralytic ileus caused by nab-paclitaxel, which will be widely used as a novel anticancer drug.
Department of Medical Oncology, Changzheng Hospital, Shanghai 200070, P.R. China.
Xiao-Dong
XD
Jiao
Department of Hematology, Tongji Hospital of Tongji University, Shanghai 200065, P.R. China.
Xiu
X
Luo
Department of Medical Oncology, Changzheng Hospital, Shanghai 200070, P.R. China.
Wen-Xing
WX
Qin
Department of Medical Oncology, Changzheng Hospital, Shanghai 200070, P.R. China.
Ling-Yan
LY
Yuan
Department of Medical Oncology, Changzheng Hospital, Shanghai 200070, P.R. China.
Yuan-Sheng
YS
Zang
complication; nab-paclitaxel; paralytic ileus